Tamrintamab pamozirine (SC-003) in patients with platinum-resistant/refractory ovarian cancer: Findings of a phase 1 study-Reference-Cited by-同舟云学术

Tamrintamab pamozirine (SC-003) in patients with platinum-resistant/refractory ovarian cancer: Findings of a phase 1 study

Published:2020-09 Issue:3 Volume:158 Page:640-645
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Hamilton Erika,O'Malley David M.,O'Cearbhaill Roisin,Cristea Mihaela,Fleming Gini F.,Tariq Bilal,Fong Abraham,French Dorothy,Rossi Michael,Brickman Daniel,Moore Kathleen

Funder

AbbVie Inc.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference19 articles.

1. Cancer statistics;Siegel;CA Cancer J. Clin.,2018

2. Ovarian cancer;Hennessy;Lancet,2009

3. Bringing new medicines to women with epithelial ovarian cancer: what is the unmet medical need?;Herzog;Gynecol. Oncol. Res. Pract.,2017

4. Treatment of recurrent ovarian cancer;Pignata;Ann. Oncol.,2017

5. Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: the AURELIA open-label randomized phase III trial;Pujade-Lauraine;J. Clin. Oncol.,2014

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Composition analysis and mechanism of Guizhi Fuling capsule in anti-cisplatin-resistant ovarian cancer;2024-09-11

2. Research progress of antibody–drug conjugates in gynecologic cancer;Holistic Integrative Oncology;2024-08-29

3. Exploration of the antibody–drug conjugate clinical landscape;mAbs;2023-08-28

4. Dipeptidase‑2 is a prognostic marker in lung adenocarcinoma that is correlated with its sensitivity to cisplatin;Oncology Reports;2023-07-11

5. Micelle encapsulation zinc‐doped copper oxide nanocomposites reverse Olaparib resistance in ovarian cancer by disrupting homologous recombination repair;Bioengineering & Translational Medicine;2023-03-28